| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2977 | Kunb31 | Novel potent and selective inhibitor of Hsp90β |
|
| DCC2978 | Kurasoin B | Novel protein farnesyltransferase inhibitor |
|
| DCC2979 | kv1.5-in-iiii | Potent Kv1.5 inhibitor |
|
| DCC2980 | Kv2.1/syntaxin-in-cpd5 | Novel neuroprotectant, inhibiting Kv2.1-syntaxin molecular interaction |
|
| DCC2981 | Kva-d-88 | Novel Preferable Phosphodiesterase 4B (PDE4B) Inhibitor, Decreasing Cocaine-Mediated Reward Properties in Vivo |
|
| DCC2982 | Ky1022 | Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer |
|
| DCC2983 | Kya1797 | Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres |
|
| DCC2984 | Kys05047 | Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells |
|
| DCC2985 | L-161240 | Potent inhibitor of LpxC and lipid A biosynthesis |
|
| DCC2986 | L-162782 | Nonpeptide agonist of angiotensin AT1 receptor |
|
| DCC2987 | L17er4 | Novel cell-permeable attenuated cationic amphiphilic lytic (ACAL) peptide, efficiently bring immunoglobulin G (IgG) and other functional proteins into cells |
|
| DCC2988 | L2-4048 | Novel Migration Inhibitory Factor (MIF) inhibitor, binding at the allosteric and tautomerase sites, blocking MIF's tautomerase CD74 receptor binding, and pro-inflammatory activities |
|
| DCC2989 | L458-bpyne | Novel γ-secretase modulator photoaffinity probe, identifying distinct allosteric binding sites on presenilin that can be exploited to reduce levels of pathogenic Aβ species |
|
| DCC2990 | L465046 (α-synuclein Amyloid Aggregation Inhibitor) | Novel inhibitor of α-synuclein amyloid aggregation for the treatment of Parkinson's disease |
|
| DCC2991 | L524-0366 | Novel inhibitor of the TWEAK-Fn14 signaling cascade |
|
| DCC2992 | L61h46 | Novel potent inhibitor of human pancreatic cancer cells |
|
| DCC2993 | L-651392 | Potent leukotriene inhibitor |
|
| DCC2994 | L-658758 | Blocker of the activity of human neutrophil elastase (NE), human proteinase-3, human macrophage metalloelastase, mouse macrophage metalloelastase and Pseudomonas aeruginosa elastase |
|
| DCC2995 | L-663581 | Novel partial agonist of the benzodiazepine receptor |
|
| DCC2996 | L-680833 | Potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase (PMNL-E) |
|
| DCC2997 | L-682679 | HIV protease inhibitor |
|
| DCC2998 | L-687306 | Novel partial agonist of muscarinic M1 receptors |
|
| DCC2999 | L-696229 | HIV-1 non-nucleoside reverse transcriptase inhibitor |
|
| DCC3000 | L-708906 | Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1) |
|
| DCC3001 | L-731988 | Inhibitor of Strand Transfer, Preventing Integration and Inhibiting HIV-1 Replication in Cells |
|
| DCC3002 | L-735821 | Inhibitor of the KCNQ1 channel |
|
| DCC3003 | L-739758 | Potent glycoprotein IIb/IIIa inhibitor |
|
| DCC3004 | L-744832 | Ras farnesyltransferase inhibitor, inhibiting in p70(s6k) phosphorylation in mammary tumors, inducing tumor regression in transgenic mice by mediating alterations in both cell cycle control and apoptosis |
|
| DCC3005 | L-749329 | Dual ET(A)/ET(B) endothelin receptor antagonist |
|
| DCC3006 | L-768673 | Class III antiarrhythmic agent, selectively blocking the slowly activating cardiac delayed rectifier potassium current Iks |
|
